Article
IGHV1 usage is associated with lymphadenopathy and aggressive disease in the TCL1 mouse model for chronic lymphocytic leukemia
2025-07-01
Abstract excerpt
<title>Abstract</title> <p> TCL1 mice are the most commonly used preclinical model for chronic lymphocytic leukemia (CLL), a B-cell malignancy characterized by clonal CD5 <sup>+</sup> B-lymphocyte accumulation. B-cell receptor (BCR) sequencing identifies two important risk markers, immunoglobulin heavy chain variable region (IGHV) mutational status and receptor stereotypy. Despite the clinical importance in pa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4f8120bf-788c-5289-91b0-442cfacea0eb
- DOI
- 10.21203/rs.3.rs-6647193/v1
